In the published article, there was an error. There was a typographical error included in the American Type Culture Collection (ATCC) reference number of phage K.
A correction has been made to Materials and Methods, Bacteriophage. This sentence previously stated:
“High-titer (2 × 1012 pfu/ml ± 1 × 101 pfu/ml) purified phage K (ATCC 19695-B1) in phage buffer (100 mM NaCl, 10 mM MgCl Tris, pH 8.0) was prepared by TAILΦR Labs of Baylor College of Medicine (Houston, TX), as previously described (Green et al., 2017; Gibson et al., 2019; Terwilliger et al., 2021). Working stocks passed in-house sterility and endotoxin testing (8 EU/mL endotoxin C). Stocks were light-protected and stored at 4°C until administration. On study day 28, animals received 0.05 ml phage [1011 ± 101 plaque forming units (pfu)] IA administered as above, or IV through an ear catheter with subsequent port flushing by saline or heparinized saline.”
The corrected sentence appears below:
“High-titer (2 × 1012 pfu/mL ± 1 × 101 pfu/mL) purified phage K (ATCC 19685-B1) in phage buffer (100 mM NaCl, 10 mM MgCl Tris, pH 8.0) was prepared by TAILΦR Labs of Baylor College of Medicine (Houston, TX), as previously described (Green et al., 2017; Gibson et al., 2019; Terwilliger et al., 2021). Working stocks passed in-house sterility and endotoxin testing (8 EU/mL endotoxin C). Stocks were light-protected and stored at 4°C until administration. On study day 28, animals received 0.05 ml phage [1011 ± 101 plaque forming units (pfu)] IA administered as above, or IV through an ear catheter with subsequent port flushing by saline or heparinized saline.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
phage, pharmacology, periprosthetic joint infection, staphylococci, pharmacokinetics
Citation
Totten KMC, Cunningham SA, Gades NM, Etzioni A and Patel R (2022) Corrigendum: Pharmacokinetic assessment of staphylococcal phage K following parenteral and intra-articular administration in rabbits. Front. Pharmacol. 13:1005123. doi: 10.3389/fphar.2022.1005123
Received
27 July 2022
Accepted
08 August 2022
Published
02 September 2022
Volume
13 - 2022
Edited and reviewed by
Alastair George Stewart, The University of Melbourne, Australia
Updates
Copyright
© 2022 Totten, Cunningham, Gades, Etzioni and Patel.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Robin Patel, patel.robin@mayo.edu
This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.